Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Neuro-Oncology Année : 2014

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma

Philippe Metellus
  • Fonction : Auteur
  • PersonId : 1002610

Domaines

Cancer

Dates et versions

hal-01707899 , version 1 (08-07-2024)

Identifiants

Citer

Emeline Tabouret, Françoise Boudouresque, Maryline Barrie, Mona Matta, Celine Boucard, et al.. Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. Neuro-Oncology, 2014, 16 (3), pp.392 - 399. ⟨10.1093/neuonc/not226⟩. ⟨hal-01707899⟩
76 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More